Emilio Russo Selected Research

Seizures (Absence Seizure)

6/2022	Antidepressants drugs for seizures and epilepsy: Where do we stand?
5/2022	The microbiota-gut-brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models.
5/2022	N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy.
2/2022	Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
1/2021	Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.
1/2021	Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults.
1/2021	Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence.
1/2021	Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
1/2021	First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat.
11/2020	Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emilio Russo Research Topics

Disease

72	Seizures (Absence Seizure) 06/2022 - 02/2003
70	Epilepsy (Aura) 06/2022 - 02/2003
27	Absence Epilepsy (Childhood Absence Epilepsy) 05/2022 - 09/2005
11	Neoplasms (Cancer) 03/2020 - 05/2009
10	Rheumatoid Arthritis 01/2018 - 01/2013
8	Drug-Related Side Effects and Adverse Reactions 01/2020 - 02/2013
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
7	Inflammation (Inflammations) 04/2021 - 04/2015
7	Status Epilepticus (Complex Partial Status Epilepticus) 11/2019 - 06/2011
6	Cognitive Dysfunction 05/2022 - 01/2016
5	Neuroinflammatory Diseases 10/2021 - 11/2014
5	Temporal Lobe Epilepsy 08/2020 - 01/2015
5	Insulin Resistance 04/2018 - 05/2015
4	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2021 - 12/2013
4	Stroke (Strokes) 01/2021 - 04/2013
4	Brain Diseases (Brain Disorder) 01/2021 - 04/2015
4	Mental Disorders (Mental Disorder) 04/2020 - 06/2013
4	Nervous System Diseases (Neurological Disorders) 11/2017 - 09/2012
4	Multiple Sclerosis 01/2017 - 04/2013
3	Generalized Epilepsy 05/2022 - 10/2018
3	Idiopathic Generalized Epilepsy 05/2022 - 12/2016
3	Chronic Renal Insufficiency 01/2022 - 01/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2021 - 01/2018
3	Sleepiness 01/2021 - 01/2021
3	Hypoglycemia (Reactive Hypoglycemia) 12/2020 - 01/2018
3	Fibrosis (Cirrhosis) 01/2020 - 09/2011
3	Pain (Aches) 01/2020 - 06/2013
3	Psoriatic Arthritis 01/2018 - 12/2013
3	Hippocampal Sclerosis 11/2017 - 01/2015
3	Reflex Epilepsy (Photosensitive Epilepsy) 12/2016 - 03/2016
3	Parkinson Disease (Parkinson's Disease) 11/2016 - 04/2013
3	Schizophrenia (Dementia Praecox) 01/2015 - 09/2007
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 01/2021
2	Cysts 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 11/2021 - 09/2019
2	Ulcerative Colitis 07/2021 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2021 - 01/2020
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2021 - 01/2021
2	Obesity 01/2021 - 11/2020
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021 - 01/2021
2	Atrial Fibrillation 01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

36	Pharmaceutical PreparationsIBA 05/2022 - 08/2008
34	Anticonvulsants (Antiepileptic Drugs)IBA 08/2020 - 02/2003
11	perampanelIBA 02/2022 - 03/2014
11	AMPA Receptors (AMPA Receptor)IBA 01/2020 - 05/2004
8	Antidepressive Agents (Antidepressants)IBA 06/2022 - 07/2011
8	Insulin (Novolin)FDA Link 12/2020 - 01/2016
8	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2020 - 02/2003
7	CannabidiolIBA 01/2022 - 01/2016
7	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 01/2016
7	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 02/2013
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
6	Antipsychotic Agents (Antipsychotics)IBA 05/2021 - 09/2008
6	Biological ProductsIBA 04/2020 - 01/2017
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2020 - 04/2013
5	Pentylenetetrazole (Metrazol)IBA 01/2019 - 02/2003
5	AcidsIBA 01/2018 - 02/2003
4	brivaracetamIBA 02/2022 - 01/2015
4	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2016
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 12/2013
4	Butyric Acid (Butanoic Acid)IBA 01/2020 - 01/2019
4	Kainic Acid (Kainate)IBA 11/2019 - 02/2003
4	Levetiracetam (Keppra)FDA LinkGeneric 10/2019 - 08/2010
4	Carbamazepine (Tegretol)FDA LinkGeneric 05/2018 - 07/2011
4	Abatacept (Orencia)FDA Link 04/2018 - 12/2013
4	Complement C3 (C3 Complement)IBA 01/2018 - 01/2016
4	CannabinoidsIBA 11/2017 - 09/2013
4	Tryptases (Tryptase)IBA 10/2015 - 01/2013
3	Immunoglobulin E (IgE)IBA 05/2022 - 03/2016
3	Lacosamide FDA Link 02/2022 - 01/2016
3	CenobamateIBA 02/2022 - 01/2021
3	methylglyoxal bis(3-aminopropylamidinohydrazone)IBA 01/2022 - 01/2021
3	Transaminases (Aminotransferases)IBA 01/2021 - 12/2014
3	CytokinesIBA 10/2020 - 11/2014
3	SuspensionsIBA 10/2020 - 08/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 06/2013
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2016
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2017
3	Ethosuximide (Zarontin)FDA LinkGeneric 10/2019 - 08/2008
3	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2015
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2016 - 06/2013
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016 - 12/2012
3	TOR Serine-Threonine KinasesIBA 01/2016 - 06/2013
3	Sirolimus (Rapamycin)FDA Link 11/2014 - 06/2013
3	Lamotrigine (Lamictal)FDA LinkGeneric 10/2013 - 02/2013
3	2- acetyl- 1- (4'- chlorophenyl)- 6,7- dimethoxy- 1,2,3,4- tetrahydroisoquinolineIBA 08/2008 - 01/2004
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 06/2022 - 06/2015
2	Fluoxetine (Prozac)FDA LinkGeneric 06/2022 - 06/2015
2	Sertraline (Zoloft)FDA LinkGeneric 06/2022 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 05/2022 - 01/2020
2	eslicarbazepine acetateIBA 02/2022 - 12/2017
2	PrebioticsIBA 01/2022 - 10/2021
2	ixekizumabIBA 05/2021 - 01/2020
2	MineralsIBA 04/2021 - 01/2021
2	Cathepsin KIBA 04/2021 - 01/2021
2	AnticoagulantsIBA 01/2021 - 01/2018
2	edoxabanIBA 01/2021 - 01/2018

Therapy/Procedure

37	Therapeutics 05/2022 - 05/2012
6	Aftercare (After-Treatment) 05/2021 - 04/2015